Evermay Wealth Management’s Biogen BIIB Stock Holding History

Evermay Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08K	Hold	5	–	–	﹤0.01%	614
2026 Q1	$917	Hold	5	–	–	﹤0.01%	564
2025 Q4	$880	Hold	5	–	–	﹤0.01%	538
2025 Q3	$701	Hold	5	–	–	﹤0.01%	517
2025 Q2	$628	Hold	5	–	–	﹤0.01%	531
2025 Q1	$685	Hold	5	–	–	﹤0.01%	539
2024 Q4	$765	Hold	5	–	–	﹤0.01%	533
2024 Q3	$970	Hold	5	–	–	﹤0.01%	563
2024 Q2	$1.16K	Hold	5	–	–	﹤0.01%	563
2024 Q1	$1.08K	Sell	5 -1	-17%	-$234	﹤0.01%	565
2023 Q4	$1.55K	Buy	6 +1	+20%	+$246	﹤0.01%	532
2023 Q3	$1.29K	Hold	5	–	–	﹤0.01%	518
2023 Q2	$1.43K	Hold	5	–	–	﹤0.01%	509
2023 Q1	$1.39K	Hold	5	–	–	﹤0.01%	492
2022 Q4	$1.39K	Hold	5	–	–	﹤0.01%	503
2022 Q3	$1K	Hold	5	–	–	﹤0.01%	490
2022 Q2	$1K	Sell	5 -40	-89%	-$8.18K	﹤0.01%	489
2022 Q1	$9K	Sell	45 -10	-18%	-$2.17K	﹤0.01%	423
2021 Q4	$13K	Sell	55 -27	-33%	-$6.94K	﹤0.01%	382
2021 Q3	$23K	Hold	82	–	–	﹤0.01%	323
2021 Q2	$28K	Buy	+82	New	+$24.8K	0.01%	331

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evermay Wealth Management's BIIB Position: Q2 2026 in Review

Evermay Wealth Management held its Biogen (BIIB) position steady in Q2 2026 at 5 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #614.

Evermay Wealth Management first reported a position in BIIB in Q2 2021 and has held it in 21 quarters since. The position peaked at $28K in Q2 2021. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Evermay Wealth Management held 5 shares of Biogen worth $1.08K as of Q2 2026.
Evermay Wealth Management left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Evermay Wealth Management's portfolio in Q2 2026, its #614 holding.
Evermay Wealth Management first reported a position in Biogen in Q2 2021 and has held it in 21 quarters since.
Evermay Wealth Management's Biogen position peaked at $28K in Q2 2021.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Evermay Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.